nitinol and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

nitinol has been researched along with Leukemia--Myelogenous--Chronic--BCR-ABL-Positive* in 1 studies

Other Studies

1 other study(ies) available for nitinol and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

Article	Year
Influence of Tyrosine Kinase Inhibitor, Nilotinib, on Delayed Healing of Bare-Metal Stents in Superficial Femoral Arteries: Insights From Angioscopic Findings. JACC. Cardiovascular interventions, 2019, 05-27, Volume: 12, Issue:10 Topics: Aged; Alloys; Angioscopy; Antineoplastic Agents; Endovascular Procedures; Femoral Artery; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Neointima; Peripheral Arterial Disease; Predictive Value of Tests; Protein Kinase Inhibitors; Pyrimidines; Stents; Time Factors; Treatment Outcome; Wound Healing	2019

Article

Year

Influence of Tyrosine Kinase Inhibitor, Nilotinib, on Delayed Healing of Bare-Metal Stents in Superficial Femoral Arteries: Insights From Angioscopic Findings.

JACC. Cardiovascular interventions, 2019, 05-27, Volume: 12, Issue:10

Topics: Aged; Alloys; Angioscopy; Antineoplastic Agents; Endovascular Procedures; Femoral Artery; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Neointima; Peripheral Arterial Disease; Predictive Value of Tests; Protein Kinase Inhibitors; Pyrimidines; Stents; Time Factors; Treatment Outcome; Wound Healing

2019